Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    UK vs US: what makes a successful immunisation programme?

    White Papers and Resources | October 30, 2019 | Blue Latitude Health

    Emily Macdonald calls on her experience as a public health nurse specialising in the prevention of infectious disease in both the US and UK, to explore the differences between immunisation...

    Bedrock are in the Top 3

    Press Releases | October 29, 2019 | Bedrock Healthcare Communications

    Bedrock named No. 3 Young Agency by PMLive

    Are we ready for an Alzheimer’s disease modifying treatment

    White Papers and Resources | October 29, 2019 | Blue Latitude Health

    Millions of people across the globe have Alzheimer’s disease and currently, there is no cure. But if a new therapy entered the market today, would healthcare systems be ready for...

    Millennial Physicians And Digital Health Services

    Videos and Podcasts | October 23, 2019 | Wilmington Healthcare

    Can Millennial Physicians and Digital Health Services Fix the Patient-Doctor Relationship?

    Tapping the potential of rare diseases: A journey into uncharted territory

    White Papers and Resources | October 23, 2019 | Porterhouse Medical Group

    Delivering effective treatment for rare diseases remains a major unmet medical need. Fortunately, scientific advances are rapidly enhancing our ability to identify, diagnose and ultimately treat these conditions. Coupled with...

    Spotlight interview: 15 minutes on PR in pharma

    White Papers and Resources | October 17, 2019 | OPEN Health

    Vicky Bramham, Managing Director, OPEN Health takes 15 minutes to answer some key questions on PR discipline.

    eyeforpharma Marketing and Customer Innovation Europe

    White Papers and Resources | October 17, 2019 | Four Agency Worldwide

    By Richard Springham

    Wilmington Healthcare appoints new consultants

    Press Releases | October 17, 2019 | Wilmington Healthcare

    Healthcare intelligence provider Wilmington Healthcare, which incorporates HSJ, Interactive Medica and OnMedica, has expanded its team with the appointment of two new senior consultants - Roger Tomlins and Sarah Shield.

    What is changing in cardiovascular disease care?

    White Papers and Resources | October 16, 2019 | Wilmington Healthcare

    Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma

    PANDAS/PANS Awareness: A parent’s story

    White Papers and Resources | October 15, 2019 | Porterhouse Medical Group

    To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS